Altos Labs hires Joan Mannick, ex-CEO of Tornado Therapeutics, as chief medical officer and head of product development

Altos Labs/Cellular rejuvenation programming

Altos Labs appointed Dr. Joan Mannick as chief medical officer and head of product development, bringing expertise in aging-focused drug development from roles at Tornado Therapeutics, resTORbio, Life Biosciences, and Novartis. The appointment indicates Altos is transitioning toward human clinical applications of its partial epigenetic reprogramming technology.

• Mannick collaborated with Altos' Institute of Medicine and discovery teams to guide clinical development of cellular rejuvenation therapies.
• Her experience includes navigating regulatory pathways for aging biology; co-founded resTORbio, a company targeting mTOR for aging.
• Signals Altos is preparing to advance its partial epigenetic reprogramming programs toward human trials.